OBJECTIVE: To investigate the neuromuscular activity of the gastrointestinal tract by antroduodenal manometry in @entity1 with @entity46 documented by laparoscopy, to assess the effects of diet and drug therapy on symptoms, and to assess the @entity6124 that is commonly associated with these @entity66 . DESIGN: Prospective, open-label study. SETTING: A clinical center for the care of @entity1 's health. @entity1 (S): Fifty @entity1 with @entity46 documented by laparoscopy and @entity344 characterized by chronic @entity490 , @entity390 , @entity391 , early satiety, bloating and distention, and altered bowel habits. INTERVENTION(S): Motility of the gastrointestinal tract was recorded and @entity6124 was assessed. Treatment consisted of dietary changes, including reduction of glycemic @entity3363 , balancing with omega 9 oils, elimination of foods with @entity5834 and @entity6114 , and addition of @entity9539 , as well as drug therapy with @entity2053 (0.25 mg 3 times per day). RESULT(S): All 50 @entity1 showed a characteristic motility change (ampulla of @entity2473 , a @entity410 equivalent of the enteric nervous system). Forty of the @entity1 showed @entity6124 . There was a significant reduction in the total symptom score after 8 weeks of treatment. CONCLUSION(S): This study suggests that @entity46 and @entity344 are a result of the dysfunction of hollow organs. Correction of the biochemical imbalance of the eicosanoid system and the hypersecretion of insulin that results from excessive intake of glycemic @entity3363 and lack of essential @entity1718 significantly decreases symptoms in @entity1 with @entity46 and associated @entity4094 of the gastrointestinal tract.

Relation of XXXX of the gastrointestinal tract: new insights.

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'PATIENT'] @entity4094 :: ('MESH:D009468', 'Disease') :: ['neuromuscular disease'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure'] @entity390 :: ('MESH:D009325', 'Disease') :: ['nausea'] @entity66 :: ('MESH:D004194', 'Disease') :: ['nerve diseases'] @entity391 :: ('MESH:D014839', 'Disease') :: ['vomiting'] @entity5834 :: ('MESH:D002110', 'Chemical') :: ['caffeine'] @entity344 :: ('MESH:D005767', 'Disease') :: ['gastrointestinal tract symptoms'] @entity46 :: ('MESH:D004715', 'Disease') :: ['endometriosis'] @entity2473 :: ('MESH:D013035', 'Disease') :: ['Vater-duodenal wall spasm'] @entity490 :: ('MESH:D015746', 'Disease') :: ['abdominal pain'] @entity9539 :: ('MESH:D015525', 'Chemical') :: ['omega 3 fatty acids'] @entity6124 :: ('MESH:D001765', 'Disease') :: ['bacterial overgrowth'] @entity1718 :: ('MESH:D005227', 'Chemical') :: ['fatty acids'] @entity2053 :: ('MESH:D002998', 'Chemical') :: ['clonazepam'] @entity3363 :: ('MESH:D002241', 'Chemical') :: ['carbohydrates'] @entity6114 :: ('MESH:D014439', 'Chemical') :: ['tyramine']
@entity4094 :: (MESH:D009468,Disease) :: ['endometriosis and neuromuscular disease']
